650 likes | 3.44k Views
Local anesthetic systemic toxicity. HistoryMechanisms Patterns of LA toxicitySummary. Early reports of LA mortality. AMA committee reviews 57 deaths from LAs [Mayer et al JAMA 1924;82:876-85; JAMA 1928;90:1290-1]3 deaths after 22,351 gastroscopies attributed to cocaine or tetracaine [Schindler A
E N D
1. Local anestheticsystemic toxicity John Butterworth, MD
Professor & Head
Section on Cardiothoracic Anesthesiology
Wake Forest University School of Medicine
Winston-Salem, North Carolina
2. Local anestheticsystemic toxicity History
Mechanisms
Patterns of LA toxicity
Summary
3. Early reports of LA mortality AMA committee reviews 57 deaths from LAs [Mayer et al JAMA 1924;82:876-85; JAMA 1928;90:1290-1]
3 deaths after 22,351 gastroscopies attributed to cocaine or tetracaine [Schindler Am J Dig Dis 1940;7:293]
7 deaths in 39,278 uses of cocaine or tetracaine in North American otolaryngology clinics [Ireland et al Laryngoscope 1951;61:767-77]
4. FDA and systemic toxicity from LAs Cardiac arrest without prior CNS toxicity bupivacaine & etidocaine (Albright, 1979)
Black box warning in package insert
Bupivacaine 1983
No black box warning
Ropivacaine 1997
Levobupivacaine 1999)
5. Local anestheticsystemic toxicity History
Mechanisms
Patterns of LA toxicity
Summary
6. LAs bind and inhibit many differing receptors and channels Channels
Na Control
7. LAs bind and inhibit many differing receptors and channels Channels
Na
Ca (multiple types)
K
8. LAs bind and inhibit many differing receptors and channels Channels
Na
Ca (multiple types)
K
9. LAs bind and inhibit many differing receptors and channels Channels
Na
Ca
K
Enzymes
Adenylyl cyclase
10. LAs bind and inhibit many differing receptors and channels Channels
Na
Ca (multiple types)
K
Enzymes
Adenylyl cyclase
Guanylyl cyclase
Lipases
11. LAs bind and inhibit many differing receptors and channels Channels
Na
Ca (multiple types)
K
Enzymes
Adenylyl cyclase
Guanylyl cyclase
Lipases Receptors
Nicotinic acetylcholine
NMDA
2-adrenergic
12. LAs bind and inhibit many differing receptors and channels Channels
Na
Ca (multiple types)
K
Enzymes
Adenylyl cyclase
Guanylyl cyclase
Lipases Receptors
Nicotinic acetylcholine
NMDA
2-adrenergic
Important for spinal, epidural, or systemic effects?
13. LAs bind and inhibit many differing receptors and channels Do not assume LA toxic side effects arise from Na channel inhibition!
14. Local anestheticsystemic toxicity History
Mechanisms
Patterns of LA toxicity
Summary
15. Patterns of LA toxicity CV system
CNS
Allergy
Treatment
16. Multiple LA actions on the cardiovascular system Electrophysiologic
Bupivacaine vs. lidocaine: faster binding, delayed unbinding from cardiac Na channels
Antiarrhythmic and proarrhythmic effects
Inhibit conduction system
Negative inotropic
Vascular
Vasoconstrict (low concentrations)
Vasodilate (high concentrations)
LA in CNS can have CV results
Interfere with resuscitation
17. LA blood concentrations producing cardiac arrest in dogs: similar rank order as for potency
18. Ventricular arrhythmias after supraconvulsant (2x) doses of LAs
19. LA infusions, cardiac arrest & resuscitation in dogs More inducible arrhythmias with B, LB than R, Li
More epi-induced VF (EpVF) & death with B than R or Li
Continued epi often needed for Li (86%) after arrest; rarely with B
20. Bupivacaine more toxic thanlevo or ropivacaine in rats Rats infused LA at 2 mg/kg/min
Asystole treated with epi .01 mg/kg + CPR
Resuscitation success: SAP >100 mmHg
B more potent than LB or R at sz, arr, asystole
Less epi needed for ropiv than bup or levo
21. Is there one common mechanism for LA-induced cardiac death? Arrhythmias (bupivacaine)?
Left-ventricular depression (lidocaine)?
Resuscitation drug failure (bupivacaine)?
Mechanism probably depends on specific drug!
22. CNS toxicity from LAs Progression of signs & symptoms with ?LA
Vertigo
Tinnitus
Ominous feelings
Circumoral numbness
Garrulousness
Tremors
Myoclonic jerks
Convulsions
CNS depression
Convulsive LA dose inversely related to LA potency
Acidosis, hypercarbia ? convulsive dose
Pregnancy lowers dose but not concentration producing convulsions
CV toxicity requires greater LA doses and concentrations than CNS toxicity
23. CNS toxicity from LAs Progression of signs & symptoms with ?LA
Vertigo
Tinnitus
Ominous feelings
Circumoral numbness
Garrulousness
Tremors
Myoclonic jerks
Convulsions
CNS depression
Convulsive LA dose inversely related to LA potency
Acidosis, hypercarbia ? convulsive dose
Pregnancy lowers dose but not concentration producing convulsions
CV toxicity requires greater LA doses and concentrations than CNS toxicity
24. LA doses and blood concentrations producing convulsions in sheep: similar rank order as for potency
25. Allergy to LAs Common misdiagnosis after accidental IV injections
True allergy more common with esters (particularly those related to PABA) than amides
Avoid PABA in sunscreens
Possible cross reaction between PABA and methylparaben (preservative in some amide LAs)
26. None of 90 patients referred for LA reactions have allergy! 0 of 90 reacted to 1:100 LA dilutions!
Few respond to undiluted LA even among 14 referred after anaphylactoid reactions
Thus, almost no patients had real LA allergy
27. Treatment of local anesthetic toxicity Apparent allergy
Steroids
Histamine (H1) blockers
With severe reactions
Intravenous fluid
Epinephrine
CNS toxicity
Dont treat minor reactions
Seizures: maintain airway, provide O2
Terminate seizure with thiopental, midazolam, or propofol
Intubate patients with full stomachs
28. Treatment of local anesthetic toxicity Apparent allergy
Steroids
Histamine (H1) blockers
With severe reactions
Intravenous fluid
Epinephrine
CNS toxicity
Dont treat minor reactions
Seizures: maintain airway, provide O2
Terminate seizure with thiopental, midazolam, or propofol
Intubate patients with full stomachs
34. Local anestheticsystemic toxicity History
Mechanisms
Patterns of LA toxicity
Summary
35. Summary LAs are not discriminating in selecting binding sites
CV toxicity
Electrophysiology vs inotropy
Specific agent
CNS toxicity
Allergy: a rare event
Resuscitation: we await the first reported use of lipid for resuscitation of a human
37. Local anestheticsystemic toxicity John Butterworth, MD
Professor & Head
Section on Cardiothoracic Anesthesiology
Wake Forest University School of Medicine
Winston-Salem, North Carolina